PLPL
Plandai Biotechnology, Inc.Company Information
- Company Name
- Plandai Biotechnology, Inc.
- CIK
- CIK0001317880
- Category
- Smaller reporting company
- Ticker: Exchange
- PLPL: OTC
- Fiscal Year End
- June 30
- Owner Organization
- Not Available
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PLPL
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2013-02-07
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 4,900,000
Institutional Sentiment
- As of
- 2015-06-30
- Institutional shares owned
- 22,150
- Shares outstanding
- 164,419,936
- Ownership
- 0.01%
Earnings Market Reaction
- Filing date
- 2016-08-17
- Price on filing date
- —
- 1-month reaction
- -49.15%
- 3-month reaction
- 10.48%
Balance Sheet
Values in millions ($)| Line item | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 1 | 0 | 0 | 1 | ||||||
| Due From Related Parties Current | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Related Parties Current | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | - | - | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Other Assets Current | 0 | 0 | - | - | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Deposit Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 6 | 6 | 7 | 8 | 9 | 10 | 9 | 8 | 9 | 8 | 8 | 8 | ||||||
| Assets | 7 | 6 | 7 | 9 | 10 | 11 | 11 | 10 | 10 | 9 | 9 | 9 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Accrued Liabilities Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable Related Parties Current | - | - | - | 0 | - | - | - | 0 | 0 | 0 | - | 0 | ||||||
| Interest Payable Current | 1 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Long Term Debt Current | - | - | - | - | 8 | 7 | - | - | - | - | - | - | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 15 | 14 | 15 | 15 | 8 | 8 | 0 | 0 | 1 | 3 | 1 | 1 | ||||||
| Convertible Notes Payable Current | 0 | 0 | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Derivative Liabilities Current | 0 | 0 | - | - | - | - | - | 0 | 0 | 2 | 0 | 0 | ||||||
| Notes Payable Current | 14 | 13 | 14 | -15 | - | - | - | -3 | - | - | - | - | ||||||
| Notes Payable Related Parties Classified Current | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Due To Related Parties Current | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | - | ||||||
| Due To Related Parties Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 1 | 1 | ||||||
| Line Of Credit | - | - | - | - | - | - | - | - | - | - | 1 | 1 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Capital Lease Obligations | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Long Term Debt Noncurrent | - | - | - | - | 6 | 7 | 13 | 12 | 11 | 10 | 10 | 9 | ||||||
| Deferred Rent Credit Noncurrent | 2 | 1 | 1 | 2 | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 17 | 16 | 16 | 17 | 16 | 16 | 15 | 13 | 13 | 14 | 13 | 12 | ||||||
| Long Term Notes Payable | - | - | - | - | - | - | - | 9 | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 31 | 30 | 30 | 30 | 30 | 22 | 22 | 22 | 15 | 9 | 8 | 8 | ||||||
| Common Stock Shares Subscriptions | 0 | 0 | 0 | 0 | - | 2 | 2 | 1 | - | 1 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -8 | -9 | -9 | -6 | -4 | -5 | -4 | -4 | -2 | -4 | -4 | -3 | ||||||
| Retained Earnings Accumulated Deficit | -39 | -38 | -37 | -36 | -34 | -28 | -27 | -26 | -18 | -15 | -11 | -11 | ||||||
| Translation Adjustment Functional To Reporting Currency Net Of Tax | 0 | 0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Redeemable Noncontrolling Interest Equity Carrying Amount | - | - | - | - | - | - | - | - | - | -1 | -1 | -1 | ||||||
| Minority Interest | -2 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | -1 | - | - | -1 | ||||||
| Liabilities And Stockholders Equity | 7 | 6 | 7 | 9 | 10 | 11 | 11 | 10 | 10 | 9 | 9 | 9 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | - | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 180 | 170 | 166 | 164 | 161 | 134 | 134 | 131 | 128 | 111 | 106 | 106 | ||||||
| Shares Outstanding | 180 | 170 | 166 | 164 | 161 | 134 | 134 | 131 | 128 | 111 | 106 | 106 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPlandai Biotechnology, Inc. (PLPL) — SEC Financial Statements & Analysis
Plandai Biotechnology, Inc. (PLPL) is a pharmaceutical preparations company. Plandai Biotechnology, Inc. trades on OTC as: PLPL. Plandai Biotechnology, Inc. (PLPL)'s most recent SEC filing is a Form 10-Q for the period ended 2016-03-31, filed with the SEC on 2016-08-17. Based on that filing, Plandai Biotechnology, Inc. carries a market cap of $11.73M, a P/E ratio of -2.38x, a P/B ratio of -1.40x, a P/S ratio of 69.25x, an enterprise value of $25.67M, and an EV/EBITDA multiple of -14.95x. On profitability, it posts a gross margin of -720.60%, an operating margin of -1493.95%, a net margin of -2911.16%, a Return on Equity (ROE) of 77.93%, a Return on Assets (ROA) of -59.68%, and a Return on Invested Capital (ROIC) of -34.23%. Per share, it reports EPS of $-0.03, diluted EPS of $-172.58, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -346.74% year-over-year, net income growth of -71.16% year-over-year, and EPS growth of -74.34% year-over-year. On the balance sheet, it maintains a current ratio of 0.01x, a quick ratio of 0.01x, working capital of $-15.26M, a debt-to-equity ratio of -2.04x, a debt ratio of 2.58, an interest coverage ratio of -1.82x, free cash flow of $-2.53M (TTM), and net debt of $13.94M. Figures sourced from SEC EDGAR.
- Market Cap
- $11.73M
- P/E TTM
- -2.38x
- EPS TTM
- $-0.03
- P/B TTM
- -1.40x
- ROE TTM
- 77.93%
- ROA TTM
- -59.68%
- Debt To Equity
- -2.04x
- Free Cash Flow TTM
- $-2.53M
- Net Revenue TTM Growth 1Y
- -346.74%
Data as of 2016-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Plandai Biotechnology, Inc. in?
Plandai Biotechnology, Inc. (PLPL) operates in the Pharmaceutical Preparations industry.
What exchange does PLPL trade on?
Plandai Biotechnology, Inc. (PLPL) trades on the OTC.
When was Plandai Biotechnology, Inc. (PLPL)'s most recent SEC filing?
Plandai Biotechnology, Inc. (PLPL)'s most recent SEC filing is a Form 10-Q for the period ended 2016-03-31, filed with the SEC on 2016-08-17.
What is PLPL's market cap?
Plandai Biotechnology, Inc. (PLPL) has a market capitalization of $11.73M as of 2016-03-31.
What is PLPL's EPS (earnings per share)?
Plandai Biotechnology, Inc. (PLPL)'s trailing twelve month EPS is $-0.03 as of 2016-03-31.
What is PLPL's ROE (return on equity)?
Plandai Biotechnology, Inc. (PLPL)'s trailing twelve month Return on Equity (ROE) is 77.93% as of 2016-03-31.
What is PLPL's ROA (return on assets)?
Plandai Biotechnology, Inc. (PLPL)'s trailing twelve month Return on Assets (ROA) is -59.68% as of 2016-03-31.
What is PLPL's ROIC (return on invested capital)?
Plandai Biotechnology, Inc. (PLPL)'s trailing twelve month Return on Invested Capital (ROIC) is -34.23% as of 2016-03-31.
What is PLPL's EV/EBITDA?
Plandai Biotechnology, Inc. (PLPL)'s trailing twelve month EV/EBITDA is -14.95x as of 2016-03-31.